Yesilirmak, N. Et Al. 2018. Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis. DOCUMENTA OPHTHALMOLOGICA , vol.136, no.1 , 95-96.

Yesilirmak, N., Telek, H. H., Sungur, G., Ozdemir, Y., Yesil, N. K., & Ornek, F., (2018). Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis. DOCUMENTA OPHTHALMOLOGICA , vol.136, no.1, 95-96.

Yesilirmak, Nilufer Et Al. "Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis," DOCUMENTA OPHTHALMOLOGICA , vol.136, no.1, 95-96, 2018

Yesilirmak, Nilufer Et Al. "Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis." DOCUMENTA OPHTHALMOLOGICA , vol.136, no.1, pp.95-96, 2018

Yesilirmak, N. Et Al. (2018) . "Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis." DOCUMENTA OPHTHALMOLOGICA , vol.136, no.1, pp.95-96.

@article{article, author={Nilufer Yesilirmak Et Al. }, title={Response to risk of hydroxychloroquine retinopathy is not related to systemic lupus erythematosus or rheumatoid arthritis}, journal={DOCUMENTA OPHTHALMOLOGICA}, year=2018, pages={95-96} }